Medical Statistics Group
- +44 (0) 1865 617300
Established in 2008
Our aim is to support clinical research in primary care and to advance the way we answer clinical questions using statistics to improve healthcare worldwide.
We are a team of statisticians, systematic reviewers, methodologists and health economists who are involved in a variety of research programmes using a wide range of expertise to develop innovative methods of analysis and monitoring in primary and secondary research, including diabetes, oral anticoagulation therapy, hypertension, cardiovascular disease and chronic kidney disease.
Professor Perera, Director of the Medical Statistics Group, has overseen the development of one of the strongest methodological/statistical groups in the UK (across all clinical areas) with a particular emphasis on monitoring, with the group achieving national and international recognition [NIHR Progress Report 2008/09-Delivering Health Research].
The team of also provides support for the design, execution and analysis of studies to all the clinical research groups in the department as well as our own individual research programmes. We are closely involved in:
We provide support to the Primary Care Clinical Trials Unit with statisticians embedded within the Trials Unit. We specialise in primary care trials and in particular the design and analysis of cluster trials.
Our group is heavily involved in teaching of both undergraduate and graduate programmes. In particular, many of our senior members act as supervisors for both the MSc in EBHC and for both of our DPhil programmes. Professor Perera also teaches for Cochrane UK.
The number of people with type 2 diabetes is increasing globally, a condition that disproportionately affects South Asians. Text messages to support people to manage their diabetes show promise. They are cheap, accessible, and can positively impact blood sugar levels. Senior Qualitative Researcher Dr Suman Prinjha writes about her research (published in JMIR mHealth and uHealth) on how a text messaging system could support medication use in British South Asian people with diabetes.